financetom
Business
financetom
/
Business
/
What's Going On With Semiconductor Company ASML Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Semiconductor Company ASML Stock Today?
Jul 3, 2024 8:31 AM

Shares of semiconductor parts supplier ASML Holding N.V. ( ASML ) are trading higher today.

The company has been reportedly given the go-ahead for its expansion plans at its headquarters in Veldhoven, Netherlands, following a ruling by the country’s Council of State.

The court dismissed objections from two neighbors who cited concerns about potential traffic and noise issues. This decision supports the approval granted by Veldhoven’s town council in 2022.

The Netherlands’ highest administrative court determined that the complaints were insufficient to halt the project, reported Reuters.

The court also rejected the idea of building the facilities partially underground due to the sensitive nature of ASML’s semiconductor equipment, which requires stability during assembly.

Related Read: US Pressures Japan And Netherlands To Tighten Chip Equipment Exports To China: Report

The Veldhoven expansion aims to support ASML’s immediate growth requirements. In addition, the company signed a letter of intent in April for a larger expansion project in Eindhoven, which will accommodate 20,000 new employees by 2030.

Price Action: ASML ( ASML ) shares are trading higher by 1.62% at $1,064.90 at last check Wednesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Also Read:

ASML Remains Top Pick In EU Semicaps, Analyst Highlights Key Role In AI Infrastructure And Multiple Expansion

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Confluent Insider Sold Shares Worth $252,283, According to a Recent SEC Filing
Confluent Insider Sold Shares Worth $252,283, According to a Recent SEC Filing
Mar 22, 2024
05:07 PM EDT, 03/22/2024 (MT Newswires) -- Chad Verbowski, CTO, on March 20, 2024, sold 8,086 shares in Confluent (CFLT) for $252,283. Following the Form 4 filing with the SEC, Verbowski has control over a total of 532,072 shares of the company, with 532,072 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1699838/000141588924008980/xslF345X03/form4-03222024_090331.xml Price: 30.93, Change: -0.03, Percent Change: -0.1 ...
Akamai Technologies Insider Sold Shares Worth $1,575,233, According to a Recent SEC Filing
Akamai Technologies Insider Sold Shares Worth $1,575,233, According to a Recent SEC Filing
Mar 22, 2024
05:01 PM EDT, 03/22/2024 (MT Newswires) -- Adam Karon, COO & General Manager, Edge Technology Group, on March 22, 2024, sold 14,349 shares in Akamai Technologies ( AKAM ) for $1,575,233. Following the Form 4 filing with the SEC, Karon has control over a total of 6,697 shares of the company, with 6,697 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1086222/000108622224000117/xslF345X03/wk-form4_1711140928.xml Price:...
Chemours Appoints Interim CEO Denise Dignam as Chief Executive
Chemours Appoints Interim CEO Denise Dignam as Chief Executive
Mar 22, 2024
05:02 PM EDT, 03/22/2024 (MT Newswires) -- Chemours ( CC ) said late Friday it has appointed Denise Dignam, current interim CEO, to the positions of presidentand chief executive officer and a board member, effective immediately. The firm also said Matthew Abbott will remain as interim chief financial officer while a search has begun for a permanent CFO. ...
Rhythm Pharmaceuticals Insider Sold Shares Worth $735,600, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $735,600, According to a Recent SEC Filing
Mar 22, 2024
05:01 PM EDT, 03/22/2024 (MT Newswires) -- Joseph Shulman, Chief Technical Officer, on March 21, 2024, sold 18,235 shares in Rhythm Pharmaceuticals ( RYTM ) for $735,600. Following the Form 4 filing with the SEC, Shulman has control over a total of 30 shares of the company, with 30 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465924037927/xslF345X03/tm249484-2_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved